EUCTR2007-004021-19-FI
Active, not recruiting
Phase 1
OPHO ALL-2008 Pilot Study on consolidation therapy for children and young adults with acute lymphoblastic leukaemia
ConditionsChildhood and adult A
DrugsMercaptopurine
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Childhood and adult A
- Sponsor
- Rigshospitalet
- Enrollment
- 75
- Status
- Active, not recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •B\-lineage ALL with a white blood cell count of \< 100 x 10E9/l and age at diagnosis 1\.0\-17\.9 yrs, no t(9;22\), no hypodiploidy, no 11q23(MLL)\-aberrations, no t(1;19\), no TPMT deficiency, no known intolerance to MD\-MTX and/or oral 6MP and a written consent obtained for participation.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) no
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •If not one of the above is met
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
OPHO ALL-2008 PILOT STUDY ON CONSOLIDATION THERAPY FOR CHILDREN AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA - ALL2008pEUCTR2007-004021-19-SERigshospitalet75
Active, not recruiting
Phase 1
OPHO ALL-2008 PILOT STUDY ON CONSOLIDATION THERAPY FOR CHILDREN AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA - ALL2008pAcute lymphoblastic leukemia in children 1.0-18 years of ageMedDRA version: 9.1Level: LLTClassification code 10066109Term: Precursor B-lymphoblastic leukemia acuteEUCTR2007-004021-19-DKRigshospitalet75
Active, not recruiting
Not Applicable
A Phase 2 Study of combined modality treatment with primary chemotherapy followed by endoscopic laser resection in intermediate stage laryngeal squamous cell carcinoma.SQUAMOUS CELL CARCINOMA OF THE LARYNGXMedDRA version: 6.1Level: PTClassification code 10018395EUCTR2005-001132-72-ITISTITUTO EUROPEO DI ONCOLOGIA42
Recruiting
Phase 2
Induction of remission and consolidation therapy using ATRA and ATO for acute promyelocytic leukemia - JSCT APL2021Acute promyelocytic leukemiaJPRN-jRCTs071210035Takase Ken90
Not yet recruiting
Phase 1
A study in blood cancer patients to check the effect of two oral drugs in maintaining the status of the patient disease free. The medicines that will be given are azacytidine and pomalidomide.Health Condition 1: C92A- Acute myeloid leukemia with multilineage dysplasiaCTRI/2023/09/057552Tata Memorial Centre